B
CME Group Inc.
CME
$261.85
-$0.87-0.33%
B
Buy
12/20/2024Downgrade
CME Group Inc. (CME) was downgraded to B- from B on 12/20/2024 due to a decline in the volatility index, valuation index and dividend index.
CME Group Inc. (CME) was downgraded to B- from B on 12/20/2024 due to a decline in the volatility index, valuation index and dividend index.
B
Buy
11/21/2024Upgraded
CME Group Inc. (CME) was upgraded to B from B- on 11/21/2024 due to a major increase in the solvency index, total return index and volatility index. Debt to equity declined from 0.13 to 0.12.
CME Group Inc. (CME) was upgraded to B from B- on 11/21/2024 due to a major increase in the solvency index, total return index and volatility index. Debt to equity declined from 0.13 to 0.12.
B
Buy
9/24/2024Upgraded
CME Group Inc. (CME) was upgraded to B- from C+ on 9/24/2024 due to an increase in the total return index, growth index and volatility index. EBIT increased 4.27% from $959.6M to $1B, total revenue increased 3% from $1.49B to $1.53B, and earnings per share increased from $2.35 to $2.42.
CME Group Inc. (CME) was upgraded to B- from C+ on 9/24/2024 due to an increase in the total return index, growth index and volatility index. EBIT increased 4.27% from $959.6M to $1B, total revenue increased 3% from $1.49B to $1.53B, and earnings per share increased from $2.35 to $2.42.
C
Hold
7/22/2024Upgraded
CME Group Inc. (CME) was upgraded to C+ from C on 7/22/2024 due to an increase in the total return index and volatility index.
CME Group Inc. (CME) was upgraded to C+ from C on 7/22/2024 due to an increase in the total return index and volatility index.
C
Hold
7/2/2024Downgrade
CME Group Inc. (CME) was downgraded to C from C+ on 7/2/2024 due to a decline in the total return index and volatility index.
CME Group Inc. (CME) was downgraded to C from C+ on 7/2/2024 due to a decline in the total return index and volatility index.
C
Hold
5/30/2024Downgrade
CME Group Inc. (CME) was downgraded to C+ from B- on 5/30/2024 due to a large decline in the solvency index, growth index and volatility index. Operating cash flow declined 14.52% from $1.04B to $892.7M.
CME Group Inc. (CME) was downgraded to C+ from B- on 5/30/2024 due to a large decline in the solvency index, growth index and volatility index. Operating cash flow declined 14.52% from $1.04B to $892.7M.
B
Buy
4/25/2024Upgraded
CME Group Inc. (CME) was upgraded to B- from C+ on 4/25/2024 due to an increase in the volatility index, valuation index and total return index.
CME Group Inc. (CME) was upgraded to B- from C+ on 4/25/2024 due to an increase in the volatility index, valuation index and total return index.
C
Hold
3/18/2024Downgrade
CME Group Inc. (CME) was downgraded to C+ from B- on 3/18/2024 due to a decline in the total return index and valuation index.
CME Group Inc. (CME) was downgraded to C+ from B- on 3/18/2024 due to a decline in the total return index and valuation index.
B
Buy
3/1/2024Upgraded
CME Group Inc. (CME) was upgraded to B- from C+ on 3/1/2024 due to a noticeable increase in the growth index, volatility index and efficiency index. Operating cash flow increased 21.9% from $856.7M to $1.04B, earnings per share increased from $2.06 to $2.2392, and net income increased 8.58% from $750.2M to $814.6M.
CME Group Inc. (CME) was upgraded to B- from C+ on 3/1/2024 due to a noticeable increase in the growth index, volatility index and efficiency index. Operating cash flow increased 21.9% from $856.7M to $1.04B, earnings per share increased from $2.06 to $2.2392, and net income increased 8.58% from $750.2M to $814.6M.
C
Hold
1/8/2024Downgrade
CME Group Inc. (CME) was downgraded to C+ from B- on 1/8/2024 due to a decline in the volatility index and total return index.
CME Group Inc. (CME) was downgraded to C+ from B- on 1/8/2024 due to a decline in the volatility index and total return index.
B
Buy
12/11/2023Downgrade
CME Group Inc. (CME) was downgraded to B- from B on 12/11/2023 due to a decline in the volatility index, valuation index and dividend index.
CME Group Inc. (CME) was downgraded to B- from B on 12/11/2023 due to a decline in the volatility index, valuation index and dividend index.
B
Buy
11/6/2023Upgraded
CME Group Inc. (CME) was upgraded to B from B- on 11/6/2023 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 31.72% from $650.4M to $856.7M.
CME Group Inc. (CME) was upgraded to B from B- on 11/6/2023 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 31.72% from $650.4M to $856.7M.
B
Buy
10/16/2023Upgraded
CME Group Inc. (CME) was upgraded to B- from C+ on 10/16/2023 due to an increase in the total return index and volatility index.
CME Group Inc. (CME) was upgraded to B- from C+ on 10/16/2023 due to an increase in the total return index and volatility index.
C
Hold
9/29/2023Downgrade
CME Group Inc. (CME) was downgraded to C+ from B- on 9/29/2023 due to a decline in the volatility index.
CME Group Inc. (CME) was downgraded to C+ from B- on 9/29/2023 due to a decline in the volatility index.
B
Buy
9/14/2023Upgraded
CME Group Inc. (CME) was upgraded to B- from C+ on 9/14/2023 due to an increase in the volatility index, total return index and solvency index.
CME Group Inc. (CME) was upgraded to B- from C+ on 9/14/2023 due to an increase in the volatility index, total return index and solvency index.
C
Hold
5/22/2023Upgraded
CME Group Inc. (CME) was upgraded to C+ from C on 5/22/2023 due to a noticeable increase in the volatility index, total return index and growth index. EBIT increased 39.47% from $655.1M to $913.7M, earnings per share increased from $1.7554 to $2.43, and total revenue increased 19.4% from $1.21B to $1.44B.
CME Group Inc. (CME) was upgraded to C+ from C on 5/22/2023 due to a noticeable increase in the volatility index, total return index and growth index. EBIT increased 39.47% from $655.1M to $913.7M, earnings per share increased from $1.7554 to $2.43, and total revenue increased 19.4% from $1.21B to $1.44B.
C
Hold
2/17/2023Upgraded
CME Group Inc. (CME) was upgraded to C from C- on 2/17/2023 due to an increase in the volatility index.
CME Group Inc. (CME) was upgraded to C from C- on 2/17/2023 due to an increase in the volatility index.
C
Hold
1/17/2023Downgrade
CME Group Inc. (CME) was downgraded to C- from C on 1/17/2023 due to a noticeable decline in the volatility index, total return index and efficiency index.
CME Group Inc. (CME) was downgraded to C- from C on 1/17/2023 due to a noticeable decline in the volatility index, total return index and efficiency index.
C
Hold
8/8/2022Downgrade
CME Group Inc. (CME) was downgraded to C from C+ on 8/8/2022 due to a noticeable decline in the growth index, volatility index and total return index. Operating cash flow declined 22.71% from $799.1M to $617.6M, EBIT declined 12.73% from $859.1M to $749.7M, and total revenue declined 8.15% from $1.34B to $1.23B.
CME Group Inc. (CME) was downgraded to C from C+ on 8/8/2022 due to a noticeable decline in the growth index, volatility index and total return index. Operating cash flow declined 22.71% from $799.1M to $617.6M, EBIT declined 12.73% from $859.1M to $749.7M, and total revenue declined 8.15% from $1.34B to $1.23B.
C
Hold
7/14/2022Downgrade
CME Group Inc. (CME) was downgraded to C+ from B- on 7/14/2022 due to a decline in the total return index and volatility index.
CME Group Inc. (CME) was downgraded to C+ from B- on 7/14/2022 due to a decline in the total return index and volatility index.
B
Buy
6/30/2022Downgrade
CME Group Inc. (CME) was downgraded to B- from B on 6/30/2022 due to a decline in the volatility index and total return index.
CME Group Inc. (CME) was downgraded to B- from B on 6/30/2022 due to a decline in the volatility index and total return index.
B
Buy
5/5/2022Upgraded
CME Group Inc. (CME) was upgraded to B from B- on 5/5/2022 due to a substantial increase in the growth index, valuation index and efficiency index. EBIT increased 45.36% from $591M to $859.1M, operating cash flow increased 19.57% from $668.3M to $799.1M, and total revenue increased 17.41% from $1.14B to $1.34B.
CME Group Inc. (CME) was upgraded to B from B- on 5/5/2022 due to a substantial increase in the growth index, valuation index and efficiency index. EBIT increased 45.36% from $591M to $859.1M, operating cash flow increased 19.57% from $668.3M to $799.1M, and total revenue increased 17.41% from $1.14B to $1.34B.
B
Buy
4/26/2022Downgrade
CME Group Inc. (CME) was downgraded to B- from B on 4/26/2022 due to a decline in the total return index.
CME Group Inc. (CME) was downgraded to B- from B on 4/26/2022 due to a decline in the total return index.
B
Buy
3/7/2022Upgraded
CME Group Inc. (CME) was upgraded to B from B- on 3/7/2022 due to an increase in the volatility index, growth index and valuation index. Operating cash flow increased 5.81% from $631.6M to $668.3M, and total revenue increased 3.39% from $1.11B to $1.14B.
CME Group Inc. (CME) was upgraded to B from B- on 3/7/2022 due to an increase in the volatility index, growth index and valuation index. Operating cash flow increased 5.81% from $631.6M to $668.3M, and total revenue increased 3.39% from $1.11B to $1.14B.
B
Buy
1/11/2022Upgraded
CME Group Inc. (CME) was upgraded to B- from C+ on 1/11/2022 due to an increase in the total return index and valuation index.
CME Group Inc. (CME) was upgraded to B- from C+ on 1/11/2022 due to an increase in the total return index and valuation index.
C
Hold
12/27/2021Downgrade
CME Group Inc. (CME) was downgraded to C+ from B- on 12/27/2021 due to a decline in the total return index and valuation index.
CME Group Inc. (CME) was downgraded to C+ from B- on 12/27/2021 due to a decline in the total return index and valuation index.
B
Buy
12/10/2021Upgraded
CME Group Inc. (CME) was upgraded to B- from C+ on 12/10/2021 due to a noticeable increase in the total return index and volatility index.
CME Group Inc. (CME) was upgraded to B- from C+ on 12/10/2021 due to a noticeable increase in the total return index and volatility index.
C
Hold
11/8/2021Upgraded
CME Group Inc. (CME) was upgraded to C+ from C on 11/8/2021 due to a substantial increase in the growth index, solvency index and valuation index. Earnings per share increased from $1.42 to $2.58, and operating cash flow increased 26.37% from $499.8M to $631.6M.
CME Group Inc. (CME) was upgraded to C+ from C on 11/8/2021 due to a substantial increase in the growth index, solvency index and valuation index. Earnings per share increased from $1.42 to $2.58, and operating cash flow increased 26.37% from $499.8M to $631.6M.
C
Hold
8/6/2021Downgrade
CME Group Inc. (CME) was downgraded to C from C+ on 8/6/2021 due to a major decline in the solvency index, growth index and valuation index. Operating cash flow declined 17.07% from $602.7M to $499.8M, earnings per share declined from $1.6 to $1.42, and EBIT declined 6.95% from $725.1M to $674.7M.
CME Group Inc. (CME) was downgraded to C from C+ on 8/6/2021 due to a major decline in the solvency index, growth index and valuation index. Operating cash flow declined 17.07% from $602.7M to $499.8M, earnings per share declined from $1.6 to $1.42, and EBIT declined 6.95% from $725.1M to $674.7M.
C
Hold
3/1/2021Downgrade
CME Group Inc. (CME) was downgraded to C+ from B- on 3/1/2021 due to a substantial decline in the growth index, valuation index and solvency index.
CME Group Inc. (CME) was downgraded to C+ from B- on 3/1/2021 due to a substantial decline in the growth index, valuation index and solvency index.
B
Buy
2/25/2021Upgraded
CME Group Inc. (CME) was upgraded to B- from C+ on 2/25/2021 due to an increase in the total return index, volatility index and growth index.
CME Group Inc. (CME) was upgraded to B- from C+ on 2/25/2021 due to an increase in the total return index, volatility index and growth index.
C
Hold
1/13/2021Upgraded
CME Group Inc. (CME) was upgraded to C+ from C on 1/13/2021 due to an increase in the volatility index.
CME Group Inc. (CME) was upgraded to C+ from C on 1/13/2021 due to an increase in the volatility index.
C
Hold
9/10/2020Downgrade
CME Group Inc. (CME) was downgraded to C from C+ on 9/10/2020 due to a major decline in the growth index, volatility index and valuation index. Earnings per share declined from $2.14 to $1.4, EBIT declined 33.59% from $959.9M to $637.5M, and total revenue declined 22.34% from $1.52B to $1.18B.
CME Group Inc. (CME) was downgraded to C from C+ on 9/10/2020 due to a major decline in the growth index, volatility index and valuation index. Earnings per share declined from $2.14 to $1.4, EBIT declined 33.59% from $959.9M to $637.5M, and total revenue declined 22.34% from $1.52B to $1.18B.
C
Hold
7/14/2020Upgraded
CME Group Inc. (CME) was upgraded to C+ from C on 7/14/2020 due to an increase in the volatility index, valuation index and dividend index.
CME Group Inc. (CME) was upgraded to C+ from C on 7/14/2020 due to an increase in the volatility index, valuation index and dividend index.
C
Hold
6/29/2020Downgrade
CME Group Inc. (CME) was downgraded to C from C+ on 6/29/2020 due to a decline in the volatility index and total return index.
CME Group Inc. (CME) was downgraded to C from C+ on 6/29/2020 due to a decline in the volatility index and total return index.
C
Hold
6/16/2020Downgrade
CME Group Inc. (CME) was downgraded to C+ from B- on 6/16/2020 due to a decline in the volatility index, solvency index and total return index.
CME Group Inc. (CME) was downgraded to C+ from B- on 6/16/2020 due to a decline in the volatility index, solvency index and total return index.
B
Buy
5/26/2020Downgrade
CME Group Inc. (CME) was downgraded to B- from B on 5/26/2020 due to a decline in the volatility index, total return index and valuation index.
CME Group Inc. (CME) was downgraded to B- from B on 5/26/2020 due to a decline in the volatility index, total return index and valuation index.
B
Buy
5/8/2020Upgraded
CME Group Inc. (CME) was upgraded to B from B- on 5/8/2020 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from $1.3101 to $2.14, EBIT increased 49.68% from $641.3M to $959.9M, and total revenue increased 33.73% from $1.14B to $1.52B.
CME Group Inc. (CME) was upgraded to B from B- on 5/8/2020 due to a significant increase in the growth index, valuation index and solvency index. Earnings per share increased from $1.3101 to $2.14, EBIT increased 49.68% from $641.3M to $959.9M, and total revenue increased 33.73% from $1.14B to $1.52B.
B
Buy
5/1/2020Downgrade
CME Group Inc. (CME) was downgraded to B- from B on 5/1/2020 due to a significant decline in the volatility index, total return index and solvency index.
CME Group Inc. (CME) was downgraded to B- from B on 5/1/2020 due to a significant decline in the volatility index, total return index and solvency index.
B
Buy
3/4/2019Downgrade
CME Group Inc. (CME) was downgraded to B from A on 3/4/2019 due to a significant decline in the valuation index, total return index and growth index. Operating cash flow declined 12.39% from $582.6M to $510.4M, and earnings per share declined from $1.21 to $1.0985.
CME Group Inc. (CME) was downgraded to B from A on 3/4/2019 due to a significant decline in the valuation index, total return index and growth index. Operating cash flow declined 12.39% from $582.6M to $510.4M, and earnings per share declined from $1.21 to $1.0985.
A
Buy
11/14/2018Upgraded
CME Group Inc. (CME) was upgraded to A from A- on 11/14/2018 due to an increase in the total return index and volatility index.
CME Group Inc. (CME) was upgraded to A from A- on 11/14/2018 due to an increase in the total return index and volatility index.
A
Buy
7/24/2018Downgrade
CME Group Inc. (CME) was downgraded to A- from A on 7/24/2018 due to a noticeable decline in the total return index.
CME Group Inc. (CME) was downgraded to A- from A on 7/24/2018 due to a noticeable decline in the total return index.
A
Buy
6/20/2018Downgrade
CME Group Inc. (CME) was downgraded to A from A+ on 6/20/2018 due to a decline in the total return index, valuation index and dividend index.
CME Group Inc. (CME) was downgraded to A from A+ on 6/20/2018 due to a decline in the total return index, valuation index and dividend index.
A
Buy
6/5/2018Upgraded
CME Group Inc. (CME) was upgraded to A+ from A on 6/5/2018 due to an increase in the volatility index, growth index and valuation index. Operating cash flow increased 61.7% from $510.2M to $825M, EBIT increased 40.35% from $527.9M to $740.9M, and total revenue increased 23.22% from $900M to $1.11B.
CME Group Inc. (CME) was upgraded to A+ from A on 6/5/2018 due to an increase in the volatility index, growth index and valuation index. Operating cash flow increased 61.7% from $510.2M to $825M, EBIT increased 40.35% from $527.9M to $740.9M, and total revenue increased 23.22% from $900M to $1.11B.
A
Buy
3/6/2018Upgraded
CME Group Inc. (CME) was upgraded to A from B+ on 3/6/2018 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from $0.91 to $8.6244, debt to equity declined from 0.11 to 0.1, and total revenue increased 1.03% from $890.8M to $900M.
CME Group Inc. (CME) was upgraded to A from B+ on 3/6/2018 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from $0.91 to $8.6244, debt to equity declined from 0.11 to 0.1, and total revenue increased 1.03% from $890.8M to $900M.
B
Buy
2/15/2018Downgrade
CME Group Inc. (CME) was downgraded to B+ from A- on 2/15/2018 due to a decline in the valuation index and dividend index.
CME Group Inc. (CME) was downgraded to B+ from A- on 2/15/2018 due to a decline in the valuation index and dividend index.
A
Buy
2/12/2018Downgrade
CME Group Inc. (CME) was downgraded to A- from A on 2/12/2018 due to a decline in the valuation index, volatility index and total return index.
CME Group Inc. (CME) was downgraded to A- from A on 2/12/2018 due to a decline in the valuation index, volatility index and total return index.
A
Buy
11/3/2017Downgrade
CME Group Inc. (CME) was downgraded to A from A+ on 11/3/2017 due to a decline in the valuation index, growth index and solvency index. Earnings per share declined from $1.22 to $0.91, EBIT declined 6.23% from $605.6M to $567.9M, and total revenue declined 3.66% from $924.6M to $890.8M.
CME Group Inc. (CME) was downgraded to A from A+ on 11/3/2017 due to a decline in the valuation index, growth index and solvency index. Earnings per share declined from $1.22 to $0.91, EBIT declined 6.23% from $605.6M to $567.9M, and total revenue declined 3.66% from $924.6M to $890.8M.
A
Buy
10/26/2017Upgraded
CME Group Inc. (CME) was upgraded to A+ from A on 10/26/2017 due to a noticeable increase in the total return index and volatility index.
CME Group Inc. (CME) was upgraded to A+ from A on 10/26/2017 due to a noticeable increase in the total return index and volatility index.
A
Buy
9/11/2017Upgraded
CME Group Inc. (CME) was upgraded to A from A- on 9/11/2017 due to an increase in the total return index, volatility index and efficiency index. Net income increased 4% from $399.8M to $415.8M, and total capital increased 0.98% from $22.79B to $23.01B.
CME Group Inc. (CME) was upgraded to A from A- on 9/11/2017 due to an increase in the total return index, volatility index and efficiency index. Net income increased 4% from $399.8M to $415.8M, and total capital increased 0.98% from $22.79B to $23.01B.
A
Buy
8/1/2017Downgrade
CME Group Inc. (CME) was downgraded to A- from A on 8/1/2017 due to a decline in the total return index.
CME Group Inc. (CME) was downgraded to A- from A on 8/1/2017 due to a decline in the total return index.
A
Buy
7/7/2017Upgraded
CME Group Inc. (CME) was upgraded to A from A- on 7/7/2017 due to a major increase in the total return index and volatility index.
CME Group Inc. (CME) was upgraded to A from A- on 7/7/2017 due to a major increase in the total return index and volatility index.
A
Buy
5/19/2017Upgraded
CME Group Inc. (CME) was upgraded to A- from B+ on 5/19/2017 due to an increase in the volatility index, solvency index and valuation index.
CME Group Inc. (CME) was upgraded to A- from B+ on 5/19/2017 due to an increase in the volatility index, solvency index and valuation index.
B
Buy
4/10/2017Downgrade
CME Group Inc. (CME) was downgraded to B+ from A- on 4/10/2017 due to a substantial decline in the total return index.
CME Group Inc. (CME) was downgraded to B+ from A- on 4/10/2017 due to a substantial decline in the total return index.
A
Buy
3/30/2017Downgrade
CME Group Inc. (CME) was downgraded to A- from A on 3/30/2017 due to a noticeable decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.1 to 0.11.
CME Group Inc. (CME) was downgraded to A- from A on 3/30/2017 due to a noticeable decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.1 to 0.11.
A
Buy
2/6/2017Downgrade
CME Group Inc. (CME) was downgraded to A from A+ on 2/6/2017 due to a decline in the volatility index.
CME Group Inc. (CME) was downgraded to A from A+ on 2/6/2017 due to a decline in the volatility index.
A
Buy
12/27/2016Upgraded
CME Group Inc. (CME) was upgraded to A+ from A on 12/27/2016 due to an increase in the total return index and volatility index.
CME Group Inc. (CME) was upgraded to A+ from A on 12/27/2016 due to an increase in the total return index and volatility index.
A
Buy
11/10/2016Upgraded
CME Group Inc. (CME) was upgraded to A from A- on 11/10/2016 due to a noticeable increase in the total return index.
CME Group Inc. (CME) was upgraded to A from A- on 11/10/2016 due to a noticeable increase in the total return index.
A
Buy
11/9/2016Upgraded
CME Group Inc. (CME) was upgraded to A- from B+ on 11/9/2016 due to a noticeable increase in the growth index, valuation index and efficiency index. Operating cash flow increased 106.89% from $223.5M to $462.4M, net income increased 47.7% from $320.1M to $472.8M, and earnings per share increased from $0.949 to $1.39.
CME Group Inc. (CME) was upgraded to A- from B+ on 11/9/2016 due to a noticeable increase in the growth index, valuation index and efficiency index. Operating cash flow increased 106.89% from $223.5M to $462.4M, net income increased 47.7% from $320.1M to $472.8M, and earnings per share increased from $0.949 to $1.39.
B
Buy
10/31/2016Downgrade
CME Group Inc. (CME) was downgraded to B+ from A on 10/31/2016 due to a large decline in the total return index and volatility index.
CME Group Inc. (CME) was downgraded to B+ from A on 10/31/2016 due to a large decline in the total return index and volatility index.
A
Buy
10/19/2016Upgraded
CME Group Inc. (CME) was upgraded to A from A- on 10/19/2016 due to a noticeable increase in the total return index, volatility index and valuation index.
CME Group Inc. (CME) was upgraded to A from A- on 10/19/2016 due to a noticeable increase in the total return index, volatility index and valuation index.
A
Buy
9/13/2016Upgraded
CME Group Inc. (CME) was upgraded to A- from B+ on 9/13/2016 due to an increase in the total return index and volatility index.
CME Group Inc. (CME) was upgraded to A- from B+ on 9/13/2016 due to an increase in the total return index and volatility index.
B
Buy
8/22/2016Upgraded
CME Group Inc. (CME) was upgraded to B+ from B on 8/22/2016 due to an increase in the total return index and volatility index.
CME Group Inc. (CME) was upgraded to B+ from B on 8/22/2016 due to an increase in the total return index and volatility index.
B
Buy
8/5/2016Downgrade
CME Group Inc. (CME) was downgraded to B from B+ on 8/5/2016 due to a major decline in the growth index and dividend index. Operating cash flow declined 56.99% from $519.7M to $223.5M, earnings per share declined from $1.09 to $0.949, and EBIT declined 6.32% from $601.3M to $563.3M.
CME Group Inc. (CME) was downgraded to B from B+ on 8/5/2016 due to a major decline in the growth index and dividend index. Operating cash flow declined 56.99% from $519.7M to $223.5M, earnings per share declined from $1.09 to $0.949, and EBIT declined 6.32% from $601.3M to $563.3M.
B
Buy
6/6/2016Downgrade
CME Group Inc. (CME) was downgraded to B+ from A- on 6/6/2016 due to a decline in the volatility index, valuation index and dividend index.
CME Group Inc. (CME) was downgraded to B+ from A- on 6/6/2016 due to a decline in the volatility index, valuation index and dividend index.
A
Buy
5/18/2016Upgraded
CME Group Inc. (CME) was upgraded to A- from B on 5/18/2016 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 38.92% from $374.1M to $519.7M, earnings per share increased from $0.8598 to $1.09, and EBIT increased 24.98% from $481.1M to $601.3M.
CME Group Inc. (CME) was upgraded to A- from B on 5/18/2016 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 38.92% from $374.1M to $519.7M, earnings per share increased from $0.8598 to $1.09, and EBIT increased 24.98% from $481.1M to $601.3M.
B
Buy
3/11/2016Downgrade
CME Group Inc. (CME) was downgraded to B from B+ on 3/11/2016 due to a large decline in the volatility index, total return index and valuation index.
CME Group Inc. (CME) was downgraded to B from B+ on 3/11/2016 due to a large decline in the volatility index, total return index and valuation index.
B
Buy
3/2/2016Downgrade
CME Group Inc. (CME) was downgraded to B+ from A- on 3/2/2016 due to a noticeable decline in the volatility index, growth index and solvency index. Operating cash flow declined 19.29% from $463.5M to $374.1M, earnings per share declined from $1.06 to $0.8598, and debt to equity increased from 0.1 to 0.11.
CME Group Inc. (CME) was downgraded to B+ from A- on 3/2/2016 due to a noticeable decline in the volatility index, growth index and solvency index. Operating cash flow declined 19.29% from $463.5M to $374.1M, earnings per share declined from $1.06 to $0.8598, and debt to equity increased from 0.1 to 0.11.
A
Buy
11/9/2015Upgraded
CME Group Inc. (CME) was upgraded to A- from B+ on 11/9/2015 due to a significant increase in the growth index, volatility index and valuation index. Operating cash flow increased 79.1% from $258.8M to $463.5M, earnings per share increased from $0.78 to $1.06, and EBIT increased 4.3% from $495.1M to $516.4M.
CME Group Inc. (CME) was upgraded to A- from B+ on 11/9/2015 due to a significant increase in the growth index, volatility index and valuation index. Operating cash flow increased 79.1% from $258.8M to $463.5M, earnings per share increased from $0.78 to $1.06, and EBIT increased 4.3% from $495.1M to $516.4M.
B
Buy
8/10/2015Downgrade
CME Group Inc. (CME) was downgraded to B+ from A- on 8/10/2015 due to a decline in the growth index and dividend index. Operating cash flow declined 38.22% from $418.9M to $258.8M, earnings per share declined from $0.98 to $0.78, and total revenue declined 2.69% from $842.7M to $820M.
CME Group Inc. (CME) was downgraded to B+ from A- on 8/10/2015 due to a decline in the growth index and dividend index. Operating cash flow declined 38.22% from $418.9M to $258.8M, earnings per share declined from $0.98 to $0.78, and total revenue declined 2.69% from $842.7M to $820M.
A
Buy
8/4/2015Upgraded
CME Group Inc. (CME) was upgraded to A- from B+ on 8/4/2015 due to an increase in the total return index and growth index.
CME Group Inc. (CME) was upgraded to A- from B+ on 8/4/2015 due to an increase in the total return index and growth index.
B
Buy
6/23/2015Downgrade
CME Group Inc. (CME) was downgraded to B+ from A- on 6/23/2015 due to a noticeable decline in the total return index, volatility index and growth index. Operating cash flow declined 16.64% from $502.5M to $418.9M.
CME Group Inc. (CME) was downgraded to B+ from A- on 6/23/2015 due to a noticeable decline in the total return index, volatility index and growth index. Operating cash flow declined 16.64% from $502.5M to $418.9M.
A
Buy
2/27/2015Upgraded
CME Group Inc. (CME) was upgraded to A- from B+ on 2/27/2015 due to a noticeable increase in the total return index, growth index and volatility index. Operating cash flow increased 114.56% from $234.2M to $502.5M, EBIT increased 13.52% from $430.4M to $488.6M, and total revenue increased 10.32% from $762.4M to $841.1M.
CME Group Inc. (CME) was upgraded to A- from B+ on 2/27/2015 due to a noticeable increase in the total return index, growth index and volatility index. Operating cash flow increased 114.56% from $234.2M to $502.5M, EBIT increased 13.52% from $430.4M to $488.6M, and total revenue increased 10.32% from $762.4M to $841.1M.
B
Buy
11/5/2014Upgraded
CME Group Inc. (CME) was upgraded to B+ from B on 11/5/2014 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 36.4% from $171.7M to $234.2M, earnings per share increased from $0.7896 to $0.86, and EBIT increased 4.47% from $412M to $430.4M.
CME Group Inc. (CME) was upgraded to B+ from B on 11/5/2014 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 36.4% from $171.7M to $234.2M, earnings per share increased from $0.7896 to $0.86, and EBIT increased 4.47% from $412M to $430.4M.
B
Buy
8/22/2014Upgraded
CME Group Inc. (CME) was upgraded to B from B- on 8/22/2014 due to an increase in the volatility index, valuation index and efficiency index.
CME Group Inc. (CME) was upgraded to B from B- on 8/22/2014 due to an increase in the volatility index, valuation index and efficiency index.
B
Buy
8/7/2014Downgrade
CME Group Inc. (CME) was downgraded to B- from B on 8/7/2014 due to a major decline in the growth index, volatility index and total return index. Operating cash flow declined 55.17% from $383M to $171.7M, EBIT declined 10.04% from $458M to $412M, and total revenue declined 5.89% from $777.4M to $731.6M.
CME Group Inc. (CME) was downgraded to B- from B on 8/7/2014 due to a major decline in the growth index, volatility index and total return index. Operating cash flow declined 55.17% from $383M to $171.7M, EBIT declined 10.04% from $458M to $412M, and total revenue declined 5.89% from $777.4M to $731.6M.
B
Buy
3/21/2014Downgrade
CME Group Inc. (CME) was downgraded to B from B+ on 3/21/2014 due to a decline in the valuation index and dividend index.
CME Group Inc. (CME) was downgraded to B from B+ on 3/21/2014 due to a decline in the valuation index and dividend index.
B
Buy
3/6/2014Upgraded
CME Group Inc. (CME) was upgraded to B+ from B- on 3/6/2014 due to a major increase in the growth index, volatility index and valuation index. Operating cash flow increased 194.22% from $129.8M to $381.9M.
CME Group Inc. (CME) was upgraded to B+ from B- on 3/6/2014 due to a major increase in the growth index, volatility index and valuation index. Operating cash flow increased 194.22% from $129.8M to $381.9M.
NASDAQ
03/27/2025 4:00PM Eastern
Quotes delayed
